Company news
Celyad Oncology SA news in 2025
Celyad Oncology SA's news releases, calls and decks from 2025, newest first.
Celyad Oncology: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
November 25, 2025
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
November 14, 2025
Celyad Oncology Announces Research Facility Divestiture
September 29, 2025
Celyad Oncology Reports First Half Year 2025 Financial Results
September 25, 2025
Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
September 11, 2025
Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
September 4, 2025
Celyad Oncology Announces Discontinuation of R&D Activities
August 26, 2025
Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC
August 13, 2025
Celyad Oncology Announces €1 Million Private Placement
July 28, 2025
Celyad Oncology Announces Strategic Review
June 24, 2025
Report of the Statutory Auditor on the Consolidated Annual Account 2024 ENG
April 18, 2025
Annual Report 2024 ENG
April 18, 2025
Information Note to Shareholders ENG
April 18, 2025
Celyad Oncology Reports Full Year 2024 Financial Results and Recent Business Highlights
April 2, 2025
Celyad Oncology announces the publication of the preclinical and clinical data of CYAD 211 providing proof of concept of its miRNA based shRNA platform
February 18, 2025